A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

Renal Anemia of Chronic Kidney Disease Clinical Trial

Official title:
A Non-interventional Study to Assess the Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Patients Not in Dialysis Treated With Mircera®

Status Completed

Clinical Trial Summary

This prospective, multicenter, observational study will evaluate the impact of comorbidity factors on the hemoglobin level in participants with chronic kidney disease who are not on dialysis and initiated on treatment with methoxy polyethylene glycol-epoetin beta (Mircera). Data will be collected for 9 months after initiation of methoxy polyethylene glycol-epoetin beta treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Kidney Diseases
Renal Anemia of Chronic Kidney Disease
Renal Insufficiency, Chronic

Clinical Trial Details

NCT number	NCT01756612
Study type	Observational
Source	Hoffmann-La Roche
Contact
Status	Completed
Phase
Start date	November 21, 2012
Completion date	March 25, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02625844` - Health Care Personnel Time for Anemia Management With Erythropoiesis Stimulating Agents in Hemodialysis Centers in Croatia	N/A
Completed	`NCT04885647` - A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease	Phase 2
Completed	`NCT02596945` - Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis	N/A
Completed	`NCT02540213` - Observational Study of MIRCERA in Users of Self-Application and Multidose Systems	N/A